Search Results
108 items found for "Tara L Lin"
- 📰 GPCR Weekly News, May 20 to 26, 2024
kinases – a potential pathway for GPCR-targeted drug discovery Nicola J Smith, Lauren T May, and Natasha L
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
a peripherally restricted chemogenetic system Hye Jin Kang , Brian E Krumm , Adrien Tassou , Bryan L
- Verily links up with Sosei Heptares for GPCR drug discovery
January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers have discovered the vast potential for GPCR-targeting drugs in treating a range of health conditions, from cancer and genetic disorders to inflammation and metabolic imbalances. Among those hitching their wagons to that star are Verily and Sosei Heptares, which have struck a research agreement to discover new GPCR targets that’ll fuel the development of potential drug candidates. The financial details of the strategic collaboration weren’t released, but Sosei Heptares’ past two team-ups in GPCR-based drug discovery have clocked in at $1 billion—with Genentech—and, just last November, $2.6 billion in a partnership with Neurocrine." Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, April 24 to 30, 2023
Sakmar, Debbie L. Hay, Lukas Grätz, and more. Check out some of the latest GPCR discoveries below!
- 📰 GPCR Weekly News, March 13 to 19, 2023
Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide
- Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital
June 2022 "June 15, 2022 06:30 AM EDT - In 2016, Abbie Celniker was promoted to partner at Third Rock Ventures as the firm raised just over $600 million for its fourth fund. Since then, Celniker has helped usher in an additional fund and headed a few startups as interim CEO. Coming on its 15th year, Third Rock Ventures announced its sixth fund today — and largest one by far — at a whopping $1.1 billion. Adding it all up, Third Rock has raised $3.8 billion since its inception. That money has gone to some 60 biotechs, much of it as early funding." Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, February 20 to 26, 2023
and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L-
- 📰 GPCR Weekly News, April 8 to 14, 2024
Katharina Grotsch, Bryan L Roth, Valery V Fokin et al. for their research on Virtual Screening of a
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
receptor internalization, with the same observations made for CCR2-expressing THP-1 monocytic cell line L. In line, β-Arrestin KO cells showed a major reduction in CCL14 scavenging by CCR1, in contrast with a
- 📰 GPCR Weekly News, March 27 to April 4, 2023
Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced
- Odorant receptors – a bit of smell for drug discovery
In the skin, OR51E2 was shown to play a role in human melanocyte homeostasis (Gelis L. et. al 2016) and
- Overview of adhesion GPCRs self-activation
was performed highlighted a new hydrophobic conserved motif composed of phenylalanine (F)/leucine (L)
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
Starting from previously reported intracellular CCR2 antagonists, several tetramethylrhodamine (TAMRA
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
family mediates βarrestin-independent GPCR endocytosis Valeria Robleto , Ya Zhuo , Joseph Crecelius , Sara Direct line to the Dr.
- 📰 GPCR Weekly News, May 6 to 12, 2024
Sara Marsango and Graeme Milligan for their research on the Regulation of the pro-inflammatory G protein-coupled Cardiology, Endocrinology, and Taste The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked pathway networks as cancer therapeutic targets Generation of comprehensive GPCR-transducer-deficient cell lines
- 📰 GPCR Weekly News, June 24 to 30, 2024
Prézeau, for their research on Heterodimers revolutionize the field of metabotropic glutamate receptors Kara
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
GPCR Events to keep you informed and engaged GPCR Jobs connecting candidates with positions Direct line
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Exciting event listings to keep you on your toes Direct line to all the cool cats in the GPCR community
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Heterodimerization when Expressed Heterologously in Saccharomyces cerevisiae The beta 2 adrenergic receptor cross-linked intestinal dendritic cells Methods & Updates in GPCR Research Generation of CRISPR/Cas9 modified human iPSC line
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Get ready to be blown away by our fantastic lineup of speakers HERE !
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
In a recent study on TAAR1, a GPCR linked to central nervous system disorders, researchers compared the
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
breathe new life into schizophrenia pipeline GPCR Dynamics Reveal Mechanisms for Drug Discovery DMS: Linking
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
They employed a series of phospho-mimicking mutants and assays such as linear ion trap mass spectrometry
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
BERKY consists of a membrane linker, a BRET donor, an ER/K α-helix linker, a BRET acceptor, and an active
- 📰 GPCR Weekly News, April 15 to 21, 2024
United With or Without an Additional Transmembrane Sequence Indicate Classification into Three Groups of Linkers
- 📰 GPCR Weekly News, April 1 to 7, 2024
Classified GPCR News from April 1st to 7th, 2024 GPCR Activation and Signaling GPRASP1 loss-of-function links
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
different ligands inducing unique GPCR conformations that selectively activate specific cellular outcomes linked